2014 39th Congress ESMO - účast ČR

Breast cancer, metastatic

A phase III randomized, double-blind, trial comparing sorafenib plus capecitabine versus placebo plus capecitabine in the treatment of locally advanced or metastatic HER2-negative breast cancer (RESILIENCE)

Autoři: MD José Baselga, PhD; Prof. M.D. Claudio Zamagni (1961-); M.D. Patricia Gomez; Begona Bermejo; Shigenori Nagai; prof. MUDr. Bohuslav Melichar, Ph.D.; Prof. M.D. Arlene Chan; M.D., MED. HABIL Laszlo Mangel (1964-); Jonas Bergh, MD, PhD; Frederico Perego Costa; Henry Gomez; Prof. M.D. William J. Gradishar; MD Clifford A. Hudis, FACP; M.D. Bernardo Rapoport; M.D. Henri Roche; Patricia Maeda; Liping Huang; M.D. Joshua Zhang, Ph.D.; M.D. Lee Schwartzberg, FACP
Číslo abstraktu: LBA8
Kategorie: Zhoubné nádory prsu

Gastrointestinal tumours, colorectal

Ramucirumab (RAM) as Second-Line Treatment in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC) Following First-Line Therapy with Sorafenib: Results from the Randomized Phase III REACH Study

Autoři: M.D. Andrew Xiuxuan Zhu, Ph.D.; Baek-Yeo Ryoo; Chia Jui Yen; Masatoshi Kudo; Prof. M.D. Ronnie Tung Ping Poon; Davide Pastorelli (1960-); M.D. Jean Frederic Blanc, Ph.D.; M.D. Hyun Cheol Chung, Ph.D.; Dr. Ari Baron; Tulio Eduardo Pfiffer; M.D. Takuji Okusaka; MUDr. Kateřina Kubáčková; Jorg Trojan; Javier Sastre; M.D. Ian Chau; M.D. Shao-Chun Chang, Ph.D.; M.D. Paolo Abada; Ling Yang; Prof. Dr. Jonathan Schwartz; Joon Oh Park
Číslo abstraktu: LBA16
Kategorie: Gastrointestinální nádory

Haematological malignancies

Carfilzomib (K) vs low-dose corticosteroids and optional cyclophosphamide (Cy) in patients (pts) with relapsed and refractory multiple myeloma (RRMM): Results from a phase 3 study (FOCUS)

Autoři: Prof. MD Heinz Ludwig; MD Tamas Masszi, PhD; MD Maria Teresa Petrucci; MD Antonio P. Palumbo; MD Laura Rosiñol, PhD; MD Arnon Nagler, MSc.; Prof. M.D. Kwee Yong; MUDr. Jiří Minařík, Ph.D. ; Meletios Athanasios Dimopoulos, MD; Doc. MUDr. Vladimír Maisnar, Ph.D.; M.D. Davide Rossi; MD Hedwig Kasparu; M.D. Dina Ben-Yehuda; Izhar Hardan; Dr. Matthew Jenner, MBBS, MRCP, FRCPath; Kanya Rajangam; Prof. M.D. Jesús San Miguel, Ph.D.; prof. MUDr. Roman Hájek, CSc.
Číslo abstraktu: LBA28
Kategorie: Mnohočetný myelom

Postery

NEMO: A phase 3 trial of binimetinib (MEK162) versus dacarbazine in patients with advanced NRAS-mutant melanoma who are untreated or have progressed after any number of immunotherapy regimens

Autoři: Prof. M.D. Reinhard Dummer; prof. MUDr. Petr Arenberger, DrSc., MBA., FCMA; M.D. Paolo Antonio Ascierto (1964-); Jan Willem De Groot; M.D. Sigrun Hallmeyer; Prof. M.D. Georgina V. Long, BSc PhD MBBS FRACP; M.D. Michal Lotem; M.D. Maria Marples; Prof. M.D. Dirk Schadendorf; M.D. Alexander N. Starodub; M.D. Matthew Hiram Taylor; Pascal Wolter; M.D. Naoyai Yamazaki, Ph.D.; Ernesto Wasserman; James Ford; Marine Weill; Keith Flaherty
Číslo abstraktu: 1130TiP
Kategorie: Maligní melanom a nádory kůže

Treatment satisfaction, symptom control, and quality of life (QoL) with lanreotide autogel (LAN) in neuroendocrine tumour (NET) patients with carcinoid syndrome (CS): results from the SymNET study

Autoři: Prof. M.D. Philippe B. Ruszniewski; Prof. M.D. Martyn E. Caplin, FRCP; M.D. Juan W. Valle; Catherine Lombard-Bohas; Graeme John Poston; M.D. Petros Perros, BSc, MBBS, FRCP; Doc. MUDr. Luboš Holubec (jr.), Ph.D., MBA; Prof. M.D. Gianfranco Delle Fave; Denis Michel Smith; Patricia Niccoli; Pascal Maisonobe; Philippe Atlan
Číslo abstraktu: 1134PD
Kategorie: Gastrointestinální nádory

Quality of life (QoL) with lanreotide autogel (LAN) vs. placebo in patients with enteropancreatic neuroendocrine tumours (EP-NETs): results from the CLARINET phase III study

Autoři: Prof. M.D. Philippe B. Ruszniewski; Prof. M.D. Martyn E. Caplin, FRCP; Prof. Dr. Marianne E. Pavel, M.D.; Prof. M.D. Jaroslaw B. Cwikla; Prof. M.D. Alexandria T. Phan; M.D. Markus Raderer; MUDr. Eva Sedláčková, MBA; Prof. M.D. Guillaume Cadiot, Ph.D.; M.D. Lucy R. Wall ; M.D. Guido Rindi, Ph.D.; Alison Langley; Joelle Blumberg
Číslo abstraktu: 1136PD
Kategorie: Gastrointestinální nádory

Identifying biological and clinical characteristics of patients with gastrointestinal stromal tumours (GIST) responding to imatinib therapy for more than 5 and 10 years

Autoři: Jacob Bosma, Ph.D.; Michiel Verboom, Ph.D.; Ithar Gataa; Erik van Werkhoven; M.D. Hans Gelderblom, Ph.D.; Prof. M.D. Ron H.J. Mathijssen, Ph.D.; M.D. Anna Reyners, Ph.D.; Czeslaw Osuch; Prof. n. med. Janusz Siedlecki; MUDr. Kateřina Kubáčková; doc. MUDr. Ilona Kocáková, Ph.D.; BSc Elzbieta Bylina; Dr. Axel Le Cesne; Dr. Piotr Rutkowski; M.D. Neeltje Steeghs, Ph.D.
Číslo abstraktu: 1430P
Kategorie: Nádorová biologie/imunologie/genetika a buněčná terapie

PR - Unplanned pregnancy during cancer treatment - on behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP)

Autoři: Sarah van Peer; M.D. Sileny Han; M.D. Karina Dahl Steffensen, Ph.D.; prof. MUDr. Michael Halaška, DrSc.; Mina (Mhallem) Gziri; Kristel van Calsteren; M.D. Frédéric Amant, Ph.D.
Číslo abstraktu: 1527P
Kategorie: Zhoubné gynekologické nádory

POSEIDON Phase I/II trial: Abituzumab combined with cetuximab plus irinotecan as second-line treatment for patients with KRAS wild-type metastatic colorectal cancer

Autoři: Elena Élez; doc. MUDr. Ilona Kocáková, Ph.D.; Dr. Thomas Höhler; M.D. Uwe Marc Martens; Prof. Dr. med. Carsten Bokemeyer; Eric Van Cutsem; prof. MUDr. Bohuslav Melichar, Ph.D.; MUDr. Martin Šmakal; Dr. Tibor Csőszi; M.D. Eldar Topuzov, Ph.D.; Prof. Dr. Rashida Orlova; Sergei Tjulandin; Fernando Rivera; Joseph Straub; Rando Bruns; Sonia Quaratino ; Josep Tabernero, MD
Číslo abstraktu: 507PD
Kategorie: Kolorektální karcinom

BATON-CRC: A phase 2 randomized trial comparing tivozanib (tivo) + mFOLFOX6 with bevacizumab (bev) + mFOLFOX6 in stage IV metastatic colorectal cancer (mCRC)

Autoři: M.D. Al B. Benson III; M.D. John A. Bridgewater; doc. MUDr. Igor Kiss, Ph.D., MBA; Dr. Ferry Eskens; Jihong Chen; Carolyn Sasse; Sandra Vossen; Chip van Sant; Howard Ball; Anne Keating; Andrew Krivoshik
Číslo abstraktu: 533P
Kategorie: Kolorektální karcinom

Safety and efficacy of panitumumab (pmab) monotherapy in recurrent or progressive metastatic colorectal cancer (mCRC): Results from a non-interventional study (VECTIS)

Autoři: doc. MUDr. Radek Lakomý, Ph.D.; MD Wojciech Rogowski; Dr. Béla Pikó; Zhasmina Mihaylova; MUDr. Eva Pritzová; Ing. MUDr. Lucia Kvočeková
Číslo abstraktu: 550P
Kategorie: Kolorektální karcinom

Long-term efficacy and safety of enzalutamide monotherapy in hormone-naive prostate cancer: 2-year follow-up

Autoři: Prof. M.D. Bertrand F. Tombal, Ph.D.; Prof. M.D. Michael Borre; M.D. Per Rathenborg; M.D. Patrick Werbrouck; Prof. M.D. Hendrik Van Poppel; Prof. M.D. Axel Heidenreich; Peter Iversen; M.D. Johan Braeckman; Doc. MUDr. Jiří Heráček, Ph.D.; M.D. Edwina Baskin-Bey; Taoufik Ouatas; M.D. Frank Perabo; De Phung; Benoit Baron; M.D. Mohammad Hirmand; M.D. Matthew Raymond Smith, Ph.D.
Číslo abstraktu: 766PD
Kategorie: Genitourinární nádory

Reasons for patients (Pts) discontinuing study treatment (Tx) in the phase 3 ALSYMPCA trial of radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) with bone metastases (Mets)

Autoři: John P. Logue; Dr. Steffen Wedel; MUDr. Aleš Chodacki; MD A. Oliver Sartor; Sten Nilsson ; M.D. Robert Edward Coleman; Prof. Dr. Nicholas James; Anne-Kirsti Aksnes; Mona Wahba; Chris Parker
Číslo abstraktu: 770P
Kategorie: Genitourinární nádory

Analysis of overall survival (OS) for patients (pts) with different prognostic risk factors treated with cabazitaxel and prednisone (Cbz + P) after docetaxel (D) in the TROPIC trial

Autoři: Dr. Kim Chi; Prof. MD Johann S. De Bono, FRCP; Dr. Amit Bahl; Dr. Stephane Oudard; Prof. M.D. Bertrand F. Tombal, Ph.D.; Prof. Dr. Mustafa Özgürolu; Steinbjørn Hansen; MUDr. Ivo Kocák, Ph.D.; Dr. Gwenaëlle Gravis; Liji Shen; Zhen Su; MD A. Oliver Sartor
Číslo abstraktu: 771P
Kategorie: Genitourinární nádory

Analysis of European patients enrolled in a global early access protocol with abiraterone acetate for metastatic castration-resistant prostate cancer progressing after chemotherapy

Autoři: M.D. Daniel Castellano; Sergio Bracarda; M.D. Marcello Tucci; MUDr. Otakar Čapoun; Vsevolod Matveev; M.D. György Bodoky, Ph.D.; M.D. George Fountzilas; Prof. Dr. Gabriel Kacso; Prof. M.D. Michael Borre; M.D. Iwona A. Skoneczna; Anil Londhe; Peter De Porre; Dr. Dan Atlan, MSc; Betty Goon; Emma Lee, Ph.D.; M.D. Tracy McGowan; Vahid Naini; M.D. Arturo Molina; Dr. Cora Sternberg
Číslo abstraktu: 781P
Kategorie: Genitourinární nádory

Matched cohort study on patients with cervical cancer diagnosed during pregnancy

Autoři: M.D. Frédéric Amant, Ph.D.; Catherine Uzan; M.D. Sileny Han; M.D. Robert Fruscio, Ph.D.; M.D. Karina Dahl Steffensen, Ph.D.; MUDr. Jiří Škultéty; Daniela Giuliani; Astrid Mephon; M.D. Roman Rouzier; M.D. Petronella O. Witteveen, Ph.D.; M.D. Anna Locatelli; prof. MUDr. Lukáš Rob, CSc.; prof. MUDr. Michael Halaška, Ph.D.; prof. MUDr. Michael Halaška, DrSc.
Číslo abstraktu: 925P
Kategorie: Genitourinární nádory

Pregnancy, fertility and cancer

Sentinel lymph node biopsy for breast cancer treatment during pregnancy - on behalf of the International Network of Cancer, Infertility and Pregnancy (INCIP) and the German Breast Group (GBG)

Autoři: M.D. Sileny Han; M.D. Frédéric Amant, Ph.D.; Claudia Sangalli; M.D. Sibylle Loibl, Ph.D.; Olivier Gheysens; Christianne Lok ; M.D. Karina Dahl Steffensen, Ph.D.; prof. MUDr. Michael Halaška, DrSc.; Prof. M.D. Fedro Alessandro Peccatori; Dr. Oreste Gentilini
Číslo abstraktu: 266PD-PR
Kategorie: Zhoubné gynekologické nádory

Presidential Symposium

MAGRIT, a double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of the recMAGE-A3 + AS15 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small cell lung cancer (NSCLC)

Autoři: M.D. Johan Vansteenkiste, Ph.D.; M.D. Byoung-Chul Cho, Ph.D.; M.D. Tõnu Vanakesa; M.D. Tommaso De Pas; M.D. Marcin Zielinski, Ph.D.; M.D. Moon Soo Kim; prof. dr hab. n. med. Jacek Jassem; M.D. Masahiro Yoshimura, Ph.D.; Dr. Jubrail Dahabreh; M.D. Haruhiko Nakayama; MUDr. Libor Havel; M.D. Haruhiko Kondo; M.D. Tetsuya Mitsudomi, Ph.D.; Konstantinos Zarogoulidis; Dr. Oleg Gladkov; Dr. Bart Spiessens; M.D. Vincent Brichard, Ph.D.; M.D. Channa Debruyne; Prof. M.D. Patrick Therasse; MD Nasser K. Altorki
Číslo abstraktu: 1173O
Kategorie: Zhoubné nádory plic a průdušek

COMBI-v: A randomised, open-label, Phase III study comparing the combination of dabrafenib (D) and trametinib (T) with vemurafenib (V) as first-line therapy in patients (pts) with unresectable or metastatic BRAF V600E/K mutation-positive cutaneous melanom

Autoři: Dr. Caroline Robert; Dr. Boguslawa Karaszewska; Prof. M.D. Jacob Schachter; Dr. Piotr Rutkowski; Prof. M.D. Andrzej Mackiewicz; M.D. Daniil Stroyakovskiy; Prof. M.D. Mikhail Lichinitser ; Prof. M.D. Reinhard Dummer; M.D. Florent Grange, Ph.D.; Dr. Laurent Mortier; M.D. Vanna Chiarion-Sileni; M.D. Kamil Drucis, Ph.D.; MUDr. Ivana Krajsová, MBA; M.D. Axel Hauschild; Peng Sun, Ph.D.; Stephen Rubin; Jeff Legos; Wendy Crist; Shonda Little; Prof. M.D. Dirk Schadendorf
Číslo abstraktu: LBA4
Kategorie: Maligní melanom a nádory kůže

Supportive and palliative care

Efficacy/safety of palonosetron vs ondansetron in preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric patients receiving moderately or highly emetogenic chemotherapy (MEC/HEC)

Autoři: Gabor Kovacs; M.D. Antonio Wachtel; Elena Basharova; Tulla Spinelli; Pierre Nicolas; as.MUDr. Edita Kabíčková, Ph.D.
Číslo abstraktu: 1479O
Kategorie: Podpůrná onkologická léčba, výživa nemocných a ošetřovatelská péče

Treatment and living and capacity building: Patient interaction with multidisciplinary teams (MTDs)

What patients expect from their medical team

Autoři: Jana Pelouchová
Číslo abstraktu: x
Kategorie: Ostatní